| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.006 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.0056 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |